References
- FDA summary of safety and effectiveness data (SSED). TriVisc®
- TriVisc Package Insert
- Ulucay, I. et al. Acta Orthop Traumatol Turc 2007;41: 337-342.
The use of arthroscopic debridement and viscosupplementation in
knee osteoarthritis.
- Dıraçöglu, D. et al. J Back and Musculo Rehab. 2016;16: 53.
Single versus multiple dose hyaluronic acid: Comparison of the
results.
VISCO-3® and Supartz® are trademarks of Seikagaku Corporation.
† The Adant® formulation is approved in 63 countries outside the US. Adant is manufactured by TEDEC-MEIJI FARMA and is authorized to be marketed and distributed under the trademark TriVisc.
